This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Short stature, not elsewhere classified
E4_SHORT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
958 |
4. Check minimum number of eventsNone |
958 |
5. Include endpointsNone |
958 |
6. Filter based on genotype QC (FinnGen only) |
838 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Short stature, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other endocrine disorders
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 838 | 484 | 354 |
| Unadjusted period prevalence (%) | 0.17 | 0.17 | 0.16 |
| Median age at first event (years) | 8.73 | 9.48 | 7.70 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 903
- Matched controls
- 8366
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
832.3
317.9
302
5
H01AC01
ATC
somatropin; parenteral
807.6
310.9
296
5
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
25.5
307.7
339
193
E34.35
ICD-10 Finland
Abnormal growth retardation
1526.4
307.7
511
7
E34.30
ICD-10 Finland
Short stature NOS
+∞
236.3
222
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
166.6
159
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
162.3
155
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
+∞
127.8
123
*
301
Kela drug reimbursment
Growth hormone
270.8
122.8
126
5
E34.31
ICD-10 Finland
Short stature, prenatal disorder
1050.8
102.5
101
*
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
15.9
96.2
89
57
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.3
72.1
231
613
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
+∞
70.8
69
*
602
Kela drug reimbursment
Children's severe malnutrition
6.6
58.5
104
163
E34.3
ICD-10 Finland
Short stature, not elsewhere classified
+∞
51.1
50
*
E30.09
ICD-10 Finland
Delayed puberty NOS
395.1
40.2
41
*
E30.00
ICD-10 Finland
Familial delayed puberty
135.9
38.8
42
*
Z3226
NOMESCO Finland
Physiotherapist
2.6
36.1
277
1201
Z31.5
ICD-10 Finland
Genetic counselling
3.5
35.6
142
426
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.8
29.4
70
143
L02AE02
ATC
leuprorelin; implant, parenteral
11.9
28.2
30
24
Z3231
NOMESCO Finland
Registered nurse
2.2
28.1
374
2030
RD210, ,
NOMESCO Finland
3.7
27.4
96
263
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
27.2
264
1253
R62.0
ICD-10 Finland
Delayed milestone
3.5
26.3
101
294
BF20A, ,
NOMESCO Finland
258.4
26.1
27
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
24.6
135
485
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
22.5
111
375
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
21.2
213
1013
H02AB09
ATC
hydrocortisone; systemic
3.5
20.3
76
217
127
Kela drug reimbursment
Transplant complication
5.0
20.1
45
87
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
7.7
19.9
29
36
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.2
19.7
202
965
Z2445
NOMESCO Finland
Psychologist
2.4
19.7
150
631
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.1
19.4
56
133
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
19.4
110
400
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
25.7
19.3
27
10
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
19.3
332
1919
XA800
NOMESCO Finland
Neuropsychological investigation
2.8
19.3
110
401
A11CC03
ATC
alfacalcidol; systemic
5.4
19.2
39
69
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
94.7
18.0
20
*
E34.45
ICD-10 Finland
Abnormal growth increase
41.7
17.7
22
5
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.6
17.4
60
162
R4110
NOMESCO Finland
Physiotherapy
2.0
17.4
260
1424
ZXE00
NOMESCO Finland
One hour or less
1.9
17.4
376
2324
E22.80
ICD-10 Finland
Central precocious puberty
170.0
17.0
18
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
16.9
170
803
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.9
16.8
31
50
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
16.3
261
1459
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
16.2
16
*
Z2221
NOMESCO Finland
Medical doctor
1.9
16.0
264
1487
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.0
15.7
73
238
L04AA06
ATC
mycophenolic acid; systemic
4.7
15.4
37
76
R4190
NOMESCO Finland
Nutritional therapy
2.2
15.3
156
739
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.5
15.1
30
52
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
6.3
15.1
26
39
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
15.0
84
303
P05.1
ICD-10 Finland
Small for gestational age
5.8
14.9
28
46
K06.18
ICD-10 Finland
Another gingival hyperplasia
6.2
14.7
26
40
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
14.6
104
422
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
14.5
95
371
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.8
14.4
76
265
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
14.4
205
1094
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
14.3
166
825
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
14.2
283
1683
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
75.5
14.1
16
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
12.5
14.1
25
19
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
3.0
14.1
66
216
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.6
14.0
48
129
RL140, ,
NOMESCO Finland
4.4
13.6
35
76
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
13.6
72
252
T10
ICPC
Growth delay
5.5
13.5
27
47
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
12.7
115
517
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
12.5
260
1555
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.0
12.2
56
181
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
12.1
52
162
Z2446
NOMESCO Finland
Social worker
1.9
11.9
170
903
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.1
11.9
33
76
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.3
11.6
24
43
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.4
11.5
86
356
XKC03
NOMESCO Finland
Water cystometry
5.8
11.3
21
34
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
11.2
165
885
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
11.1
52
170
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
11.0
174
954
L04AD01
ATC
ciclosporin; systemic
3.5
10.7
37
100
Z94.0
ICD-10 Finland
Kidney transplant status
4.6
10.7
26
54
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.1
10.7
30
70
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
4.2
10.7
29
66
XX4AW, ,
NOMESCO Finland
3.2
10.4
42
126
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
10.3
169
936
ZXD05
NOMESCO Finland
Urgent procedure
1.7
10.3
220
1317
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.8
10.2
32
81
ZXA10
NOMESCO Finland
Bilateral
1.9
10.2
151
811
E28.3
ICD-10 Finland
Primary ovarian failure
+∞
10.1
10
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.7
10.1
33
86
L04AX01
ATC
azathioprine; systemic
2.8
10.1
53
185
F83
ICD-10 Finland
Mixed specific developmental disorders
2.4
9.7
66
262
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.4
9.5
19
33
L04AA01
ATC
[U] ciclosporin
7.9
9.5
21
25
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.0
9.5
43
138
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
9.5
134
707
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.4
9.4
24
52
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
4.2
9.4
25
56
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
51.5
9.3
11
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
9.3
106
519
A12AA04
ATC
calcium carbonate; oral
5.3
9.2
19
34
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
9.1
69
287
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
93.6
9.1
10
*
E30.8
ICD-10 Finland
Other disorders of puberty
+∞
9.1
9
*
E34.40
ICD-10 Finland
Constitutional tall stature
+∞
9.1
9
*
2594A
ICD-9 Finland
Other endocrine disorders, Dwarfism, not elsewhere classified
+∞
9.1
9
*
K03.66
ICD-10 Finland
Tooth plaque
1.8
9.0
165
942
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
9.0
102
499
XF602
NOMESCO Finland
Bloodpressure monitoring
4.1
9.0
25
58
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
9.0
75
326
N18.8
ICD-10 Finland
Other chronic renal failure
5.1
9.0
19
35
ZY010
NOMESCO Finland
Hospital outpatient
1.9
8.9
115
588
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.0
8.8
102
502
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
4.6
8.8
21
43
ZXA05
NOMESCO Finland
Left side
2.0
8.8
104
517
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.7
8.8
47
166
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
34.4
8.7
11
*
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
3.8
8.6
26
64
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
8.6
101
500
121
Kela drug reimbursment
Severe hypofunction of sexual glands
9.4
8.6
17
17
Q87.14
ICD-10 Finland
Noonan's syndrome
22.5
8.6
12
5
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.5
8.5
52
196
BC00A, ,
NOMESCO Finland
10.0
8.4
16
15
UKC02
NOMESCO Finland
Cystoscopy
2.8
8.3
42
144
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
8.3
132
723
E30.1
ICD-10 Finland
Precocious puberty
25.8
8.2
11
*
H03AA01
ATC
levothyroxine sodium; systemic
1.9
8.1
101
510
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
7.7
8.1
18
22
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.7
8.1
26
67
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.1
8.0
81
381
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.5
7.9
425
3121
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.8
156
911
XJC10
NOMESCO Finland
Oesophageal pH monitoring
4.7
7.8
18
36
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
7.8
104
539
L04AD02
ATC
tacrolimus; systemic
3.5
7.7
27
74
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.5
7.7
19
40
R5140
NOMESCO Finland
Monitoring the use of the aid
3.2
7.7
31
93
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
7.7
119
645
RL130, ,
NOMESCO Finland
3.4
7.7
28
79
R03BA02
ATC
budesonide; inhalant
1.7
7.6
157
925
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.1
7.6
78
368
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
7.6
137
778
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
7.5
45
168
XW000
NOMESCO Finland
Bone marrow biopsy
2.8
7.5
37
125
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.2
7.5
67
300
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
3.4
7.4
27
76
R03AC03
ATC
terbutaline; inhalant
2.0
7.4
82
398
H02AB04
ATC
methylprednisolone; systemic
2.3
7.4
59
252
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.1
7.3
31
96
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.0
7.3
32
101
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
7.3
37
127
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
7.0
7.2
17
23
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
7.2
48
189
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
7.2
288
1982
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.8
7.2
104
553
ZX120
NOMESCO Finland
Intravenous
2.0
7.0
74
353
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
7.0
185
1159
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.2
7.0
58
252
H52.0
ICD-10 Finland
Hypermetropia
2.3
7.0
53
222
NF1AA
NOMESCO Finland
Hip X-ray examination
3.4
6.9
25
70
137
Kela drug reimbursment
Uraemia requiring dialysis
5.8
6.8
18
29
R4120
NOMESCO Finland
Occupational therapy
2.0
6.7
74
358
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
6.7
41
155
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
7.4
6.7
15
19
Z99.2
ICD-10 Finland
Dependence on renal dialysis
7.4
6.7
15
19
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
7.4
6.7
15
19
FM2CE, ,
NOMESCO Finland
2.0
6.7
78
385
B03XA01
ATC
erythropoietin; parenteral
6.2
6.7
17
26
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
6.5
25
73
DFF00
NOMESCO Finland
Pure tone audiometry
2.2
6.5
55
241
A03FA02
ATC
cisapride; oral, rectal
2.7
6.5
34
119
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.7
6.5
33
114
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
6.4
57
255
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
3.5
6.3
21
56
RS220, ,
NOMESCO Finland
2.8
6.3
30
100
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.2
6.3
24
70
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
6.3
146
886
ZXA00
NOMESCO Finland
Right side
1.7
6.2
106
591
Q96.3
ICD-10 Finland
Mosaicism, 45,X/46,XX or XY
65.2
6.2
7
*
RT160, ,
NOMESCO Finland
3.3
6.2
23
66
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.3
6.2
23
66
C08CA02
ATC
felodipine; oral
6.4
6.1
15
22
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
6.1
42
168
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.9
6.1
28
91
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
13.4
6.1
10
7
R1260
NOMESCO Finland
Evaluation of communicative skills
3.1
6.1
25
76
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.1
6.1
56
254
102
Kela drug reimbursment
Diabetes insipidus
+∞
6.1
6
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
6.1
6
*
E23.1
ICD-10 Finland
Drug-induced hypopituitarism
+∞
6.1
6
*
5AB14, ,
NOMESCO Finland
6.9
6.1
14
19
WW500
NOMESCO Finland
Blood transfusion
2.5
6.1
38
146
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
148
22
74.35
255.34
6.3
3.0
1.99
3.73
ug/l
1.24
148
22
135
185
7.77
86.73
1.7
1.7
19.77
20.12
ng/l
0.08
135
185
188
458
4.54
65.09
2.7
1.9
3.93
5.99
u/l
4.19
112
288
182
441
4.54
63.35
2.7
1.9
6.77
7.22
iu/l
0.13
119
284
250
775
3.75
61.98
2.9
2.5
320.82
362.19
nmol/l
2.67
244
739
328
1214
3.36
61.70
15.6
11.6
1.34
1.33
mmol/l
0.39
310
1167
69
86
7.97
47.47
2.5
2.1
0.11
0.14
nmol/l
0.83
54
74
316
1498
2.47
33.79
3.5
2.8
2.41
2.39
mmol/l
1.55
299
1394
752
5272
2.92
32.92
5.5
3.9
14.41
14.43
pmol/l
0.05
727
4855
598
3827
2.33
30.74
9.0
5.9
127.31
109.64
u/l
5.61
569
3618
55
90
5.96
29.36
1.9
2.2
148.49
128.35
ng/l
0.86
55
85
138
462
3.09
28.65
2.8
1.9
8.27
11.19
nmol/l
3.26
131
420
617
4122
2.22
26.69
4.7
3.3
33.93
35.63
mmol/mol
6.92
606
3943
794
5974
2.92
25.46
5.9
4.5
1.90
1.86
mu/l
0.58
775
5688
171
705
2.54
23.69
5.1
4.9
0.21
0.21
g/l
0.01
166
683
475
3027
1.96
21.23
1.7
1.9
0.94
3.13
u/ml
3.66
68
618
460
2926
1.93
20.39
5.7
3.4
71.76
67.51
nmol/l
3.26
447
2794
625
4460
1.97
19.00
17.4
11.2
3.40
3.60
e9/l
1.67
542
3685
183
854
2.24
18.86
4.7
3.1
20.94
22.33
%
0.76
177
821
606
4288
1.94
18.77
15.6
10.2
0.24
0.21
e9/l
1.46
530
3636
445
2853
1.88
18.70
2.2
1.7
1.54
1.66
g/l
1.19
209
1588
343
2097
1.83
16.11
12.4
7.7
38.33
38.28
g/l
0.06
321
1999
202
1036
2.04
16.09
4.7
2.9
13.29
14.19
umol/l
1.05
196
988
457
3055
1.78
15.83
22.3
11.6
1.23
1.22
mmol/l
0.44
420
2832
187
938
2.07
15.80
4.7
2.9
2.55
2.58
g/l
0.27
180
884
553
3944
1.77
14.97
16.8
11.5
0.00
0.00
e9/l
0.47
427
3032
432
2876
1.75
14.86
25.1
13.4
1.23
1.23
mmol/l
0.99
415
2756
107
444
2.40
14.29
2.9
3.6
4.87
5.02
pmol/l
0.65
100
405
596
4426
1.73
13.09
6.3
4.4
7.48
6.87
mm/h
0.91
568
4172
27
51
5.03
12.37
1.4
1.2
114.67
121.29
pmol/l
0.21
27
51
238
1433
1.73
11.00
19.7
9.9
0.65
1.07
mmol/l
0.85
189
1174
24
50
4.54
9.84
7.2
7.4
—
—
—
0
0
24
50
4.54
9.84
7.2
7.8
40355.83
659687.50
u/ml
—
6
16
21
39
5.08
9.81
9.6
8.8
—
—
—
0
0
50
173
2.78
9.66
1.5
1.4
383.55
373.17
ug/g
0.13
32
82
298
1963
1.61
9.52
3.7
3.1
2.38
2.35
mg/l
0.08
273
1746
59
226
2.52
9.35
18.9
10.1
334.57
387.27
iu/ml
0.10
14
26
168
963
1.76
9.07
1.3
1.2
—
64.80
—
0
5
21
42
4.72
9.04
1.9
2.3
3.29
3.75
mg/l
0.14
13
34
21
42
4.72
9.04
1.9
2.3
2.04
0.74
mg/l
0.68
16
36
21
42
4.72
9.04
1.9
2.3
0.75
1.21
mg/l
0.45
15
35
26
62
3.97
9.01
1.6
2.4
20.25
19.50
nmol/l
—
8
20
53
197
2.59
8.93
2.0
1.5
—
—
—
0
0
65
267
2.35
8.87
3.0
2.1
—
—
—
0
0
53
201
2.53
8.59
19.0
11.7
529.17
1285.75
u/ml
—
6
24
53
201
2.53
8.59
6.0
3.5
—
—
—
0
0
796
6710
1.84
8.01
14.1
9.3
24.40
25.22
u/l
0.49
783
6525
38
126
2.87
7.97
1.6
1.5
—
—
—
0
0
47
176
2.56
7.83
1.9
1.5
0.25
0.36
nmol/l
1.01
37
144
64
277
2.23
7.75
3.1
2.1
—
—
—
0
0
141
803
1.74
7.72
6.2
4.8
290.57
292.90
umol/l
0.09
132
764
45
167
2.57
7.64
2.2
2.0
—
—
—
0
0
110
584
1.85
7.61
2.0
1.8
2.41
2.40
mmol/l
0.37
91
496
21
51
3.88
7.13
1.8
1.7
1.14
0.88
iu/ml
0.41
11
29
60
267
2.16
6.81
3.4
3.6
10.34
21.52
mu/l
5.11
60
255
65
299
2.09
6.79
1.9
1.4
10.54
4.13
ug/l
1.20
60
288
48
195
2.35
6.76
2.3
1.9
—
—
—
0
0
151
908
1.65
6.73
2.0
1.4
384.63
276.55
u/ml
0.65
141
859
806
6896
1.77
6.60
26.4
15.6
13.21
13.09
%
2.25
800
6820
115
646
1.74
6.58
21.3
14.4
105.65
105.79
mmol/l
0.09
115
646
49
205
2.28
6.46
6.0
3.4
700.38
539.01
e6/l
1.02
37
137
49
206
2.27
6.39
6.1
3.4
176.27
204.00
e6/l
0.41
37
139
46
190
2.31
6.25
2.5
2.0
—
—
—
0
0
219
1465
1.51
6.12
4.8
3.0
8.09
7.45
e6/l
0.22
199
1295
41
163
2.39
6.07
2.5
1.5
—
—
—
0
0
43
176
2.33
5.98
2.4
2.1
65.88
78.88
—
8
8
527
4166
1.41
5.92
5.1
3.6
59.93
53.39
ug/l
0.52
507
3972
20
54
3.49
5.88
3.5
3.5
884.05
1087.00
u/ml
0.31
20
54
16
37
4.06
5.80
1.4
1.4
—
—
—
0
0
29
100
2.74
5.72
2.2
2.0
—
—
—
0
0
35
133
2.50
5.72
2.0
1.8
—
—
—
0
0
230
1580
1.47
5.58
3.2
3.4
76.02
94.90
ug/g
0.94
183
1285
25
82
2.88
5.41
5.9
5.5
—
—
—
0
0
332
2456
1.40
5.32
11.7
7.7
15.83
20.15
umol/l
1.25
311
2269
104
603
1.68
5.31
5.6
7.7
662.84
1252.26
ng/l
1.09
91
488
289
2094
1.41
5.20
7.2
3.9
0.16
0.22
e6/l
0.61
225
1479
8
5
14.94
5.19
1.0
1.0
—
—
—
0
0
43
189
2.16
5.09
3.0
3.2
—
—
—
0
0
794
6857
1.60
5.05
18.7
9.9
57.76
60.37
umol/l
1.15
781
6750
203
1395
1.45
4.85
3.9
2.9
61.38
55.69
u/l
0.78
195
1307
24
83
2.72
4.74
3.0
1.7
—
—
—
0
0
317
2366
1.37
4.68
7.5
4.1
—
—
—
0
0
308
2294
1.37
4.59
7.2
3.9
12.20
43.65
e6/l
1.72
239
1668
22
74
2.80
4.58
3.0
2.4
156.23
167.15
ug/g
0.16
22
65
159
1054
1.48
4.55
1.7
1.4
22.93
18.80
nmol/l
2.84
149
949
51
250
1.94
4.54
16.4
24.6
16.00
15.71
%
0.30
51
243
16
45
3.34
4.46
2.1
1.9
0.33
0.25
iu/ml
0.19
11
31
22
77
2.69
4.27
7.3
8.1
5.35
5.23
pmol/l
0.04
22
77
886
7959
2.67
4.18
29.2
17.2
4.56
4.61
e12/l
2.98
867
7654
194
1357
1.41
4.16
6.6
3.6
2.79
2.50
e6/l
0.15
110
691
35
155
2.14
4.11
4.1
2.0
0.94
1.16
g/l
0.77
29
141
35
155
2.14
4.11
6.2
8.3
1555.02
71.60
mg/mmol
0.50
30
145
66
363
1.74
4.11
2.3
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
149
2.16
4.10
14.9
26.8
0.28
0.35
iu/ml
1.07
20
92
885
7954
2.55
4.01
29.3
17.3
275.05
269.16
e9/l
1.77
867
7668
30
128
2.21
3.87
2.1
1.5
—
—
—
0
0
21
76
2.60
3.85
2.5
1.6
—
—
—
0
0
7
7
9.32
3.82
4.6
1.3
—
—
—
0
0
7
7
9.32
3.82
6.7
2.9
—
—
—
0
0
192
1361
1.39
3.79
6.3
3.5
0.58
0.88
e6/l
1.42
108
695
61
338
1.72
3.72
2.6
1.8
—
—
—
0
0
234
1720
1.35
3.67
2.1
1.6
98.39
96.10
pmol/l
0.41
128
956
65
369
1.68
3.64
3.4
2.1
97.21
103.58
au/ml
0.17
28
137
105
669
1.51
3.64
3.0
2.1
—
—
—
0
0
55
299
1.75
3.59
18.0
22.5
95.61
95.13
%
0.22
55
299
732
6320
1.39
3.59
24.3
12.1
139.33
139.37
mmol/l
0.26
715
6149
177
1249
1.39
3.58
5.2
4.3
2.13
1.35
mg/l
0.52
135
878
23
91
2.38
3.53
3.6
4.6
—
—
—
0
0
23
91
2.38
3.53
3.6
4.6
—
—
—
0
0
48
252
1.81
3.53
5.5
2.7
71.23
94.11
ml/min/173m2
1.44
13
71
462
3751
1.29
3.48
14.0
7.9
5.79
6.04
mmol/l
1.56
438
3413
442
3569
1.29
3.48
5.4
3.5
0.04
0.00
estimate
0.49
82
652
68
396
1.64
3.47
15.8
19.1
16.01
15.74
kpa
0.12
68
388
16
53
2.83
3.46
1.4
1.1
—
—
—
0
0
730
6312
1.37
3.44
24.7
12.1
3.94
3.92
mmol/l
1.06
709
6115
25
105
2.24
3.37
2.3
1.5
5.45
12.99
u/ml
0.91
20
87
128
862
1.44
3.37
3.2
2.1
—
—
—
0
0
6
6
9.32
3.33
3.3
1.7
—
—
—
0
0
81
498
1.56
3.31
3.0
1.8
233.49
165.43
u/ml
1.16
51
242
67
395
1.62
3.27
16.0
19.2
-1.45
-0.16
mmol/l
1.65
59
333
53
294
1.71
3.25
18.5
22.8
0.63
0.70
%
0.94
53
294
49
266
1.75
3.24
1.5
1.5
—
—
—
0
0
33
159
1.96
3.16
1.8
1.3
—
—
—
0
0
437
3558
1.27
3.09
5.3
3.5
0.00
2.30
estimate
0.50
76
656
93
599
1.49
3.08
2.3
2.5
28.90
28.68
u/l
0.02
86
489
178
1288
1.35
3.06
18.2
9.0
23.94
24.04
mmol/l
0.28
178
1281
192
1408
1.33
3.02
19.4
9.2
0.64
0.78
mmol/l
0.30
145
1033
89
574
1.48
2.94
1.7
1.5
412.47
316.73
mu/l
0.83
82
510
9
20
4.20
2.90
1.0
1.3
—
—
—
0
0
55
319
1.64
2.89
13.3
18.2
121.87
121.40
g/l
0.05
55
313
102
680
1.44
2.85
2.9
2.0
—
—
—
0
0
5
5
9.31
2.84
2.4
1.8
—
—
—
0
0
123
851
1.39
2.79
12.8
7.0
4.68
6.29
umol/l
1.44
104
698
431
3539
1.25
2.71
5.3
3.4
0.00
0.00
estimate
-0.00
79
674
106
720
1.41
2.68
1.4
1.3
134.19
153.49
u/ml
0.16
33
236
12
37
3.03
2.68
3.1
2.1
29.67
32.05
pg
0.65
12
37
24
110
2.05
2.66
1.7
1.5
—
—
—
0
0
36
190
1.79
2.66
1.5
1.3
—
76.39
—
0
8
48
276
1.65
2.62
3.3
2.0
3.15
6.25
iu/ml
—
10
41
7
14
4.66
2.56
11.0
12.1
—
—
—
0
0
54
326
1.57
2.44
2.1
1.7
—
—
—
0
0
37
204
1.71
2.38
1.1
1.1
0.57
6.56
eliau/ml
—
6
70
9
25
3.36
2.37
1.8
2.1
—
—
—
0
0
34
184
1.74
2.34
1.5
1.3
—
9.62
—
0
13
34
184
1.74
2.34
1.2
1.2
—
—
—
0
0
59
790
0.67
2.32
1.4
1.4
3.61
3.35
ratio
0.41
38
540
92
629
1.40
2.27
1.6
1.4
496.20
32495940.65
pmol/l
1.05
87
557
225
2457
0.80
2.24
2.3
2.5
—
—
—
0
0
13
262
0.45
2.22
1.2
1.3
—
—
—
0
0
29
154
1.77
2.14
1.6
1.4
—
—
—
0
0
29
154
1.77
2.14
1.6
1.3
—
1.62
—
0
5
63
407
1.47
2.12
5.2
4.0
10.27
8.93
umol/l
0.28
54
333
41
241
1.60
2.10
7.6
4.8
1.23
1.23
mmol/l
0.05
36
206
21
101
1.95
2.09
1.7
1.2
—
—
—
0
0
21
101
1.95
2.09
1.7
1.3
—
—
—
0
0
21
101
1.95
2.09
1.7
1.3
—
—
—
0
0
8
23
3.24
2.09
2.6
1.6
—
—
—
0
0
15
63
2.23
2.09
2.5
1.4
—
—
—
0
0
21
102
1.93
2.04
1.7
1.3
—
—
—
0
0
21
102
1.93
2.04
1.7
1.2
—
—
—
0
0
27
143
1.77
2.02
1.3
1.5
2.73
4.52
u/ml
1.13
15
80
6
14
3.99
2.01
3.0
2.9
—
—
—
0
0
218
1708
1.24
2.00
4.4
3.3
0.00
0.00
estimate
0.80
78
640
143
1066
1.29
1.99
8.7
6.9
30.36
30.77
s
0.42
138
1056
11
41
2.50
1.97
1.2
1.8
—
1020591.67
—
0
6
23
117
1.84
1.96
1.2
1.2
87.22
77.83
%
0.54
23
117
20
98
1.91
1.91
7.0
9.3
1.39
1.44
%
0.11
20
87
245
2613
0.82
1.90
2.4
2.7
—
—
—
0
0
9
31
2.71
1.89
1.3
2.2
—
—
—
0
0
42
256
1.55
1.88
1.5
1.4
—
—
—
0
0
42
256
1.55
1.88
1.5
1.4
—
—
—
0
0
25
133
1.76
1.86
3.6
1.9
291.70
295.86
mosm/kgh2o
0.56
20
94
21
106
1.86
1.84
1.7
1.3
—
—
—
0
0
35
206
1.60
1.82
3.0
4.2
6.83
7.44
index
0.06
24
131
41
251
1.54
1.81
3.1
2.2
1.02
1.02
ratio
0.01
31
211
6
16
3.49
1.79
2.3
1.9
—
—
—
0
0
48
631
0.69
1.75
1.2
1.4
3.50
3.24
mmol/l
0.50
28
390
16
274
0.53
1.74
1.1
2.0
—
—
—
0
0
161
1777
0.80
1.73
2.2
2.5
—
—
—
0
0
6
17
3.28
1.70
1.0
1.6
—
—
—
0
0
6
17
3.28
1.70
1.0
1.6
—
—
—
0
0
216
1720
1.21
1.69
5.5
4.8
6.89
8.71
mmol/l
5.76
202
1614
208
1656
1.21
1.63
3.8
3.0
1.02
1.02
kg/l
0.41
143
1059
58
390
1.40
1.63
1.5
1.5
1085.02
1084.62
nmol/l
0.00
45
299
20
104
1.80
1.63
5.8
6.3
5.23
4.76
kpa
2.42
20
104
49
320
1.44
1.61
3.1
2.1
—
—
—
0
0
511
4408
1.17
1.55
6.2
3.9
22.40
1334.41
e6/l
—
5
41
11
47
2.18
1.51
3.3
1.7
—
—
—
0
0
11
47
2.18
1.51
3.3
1.7
—
—
—
0
0
11
47
2.18
1.51
3.3
1.7
—
—
—
0
0
62
429
1.36
1.49
1.1
1.1
0.87
0.71
u/ml
0.07
32
221
13
60
2.02
1.48
1.0
1.1
1117.15
1669.33
miu/ml
0.87
13
60
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
80
1.87
1.48
1.3
1.3
—
—
—
0
0
141
1551
0.81
1.46
1.9
2.3
—
—
—
0
0
291
2413
1.17
1.43
4.2
3.0
0.00
0.01
estimate
1.08
68
559
5
15
3.10
1.41
2.4
1.6
—
—
—
0
0
5
15
3.10
1.41
2.4
1.6
—
—
—
0
0
58
401
1.36
1.41
1.3
1.3
—
—
—
0
0
357
3611
0.86
1.40
2.1
2.0
—
—
—
0
0
9
38
2.21
1.36
4.6
1.4
—
—
—
0
0
5
16
2.91
1.33
2.4
1.6
—
—
—
0
0
224
1834
1.17
1.28
2.2
1.9
1.26
1.21
mmol/l
0.43
214
1704
92
693
1.26
1.23
1.1
1.2
5.67
6.00
u/ml
0.08
68
526
62
446
1.31
1.19
1.1
1.2
9.78
10.99
u/ml
0.16
45
286
24
146
1.54
1.15
1.4
1.5
1.83
4.30
u/ml
1.32
12
71
0
33
0.00
1.15
0.0
1.2
—
6.86
—
0
7
103
793
1.23
1.15
2.8
3.8
875.58
1220.19
ng/l
0.43
48
414
53
634
0.76
1.14
1.5
1.3
—
—
—
0
0
5
19
2.45
1.11
2.0
2.3
—
—
—
0
0
7
130
0.49
1.10
1.4
1.7
0.44
0.49
e9/l
—
7
130
7
29
2.25
1.09
2.3
1.5
69.14
63.10
umol/l
—
7
29
15
82
1.71
1.09
1.3
1.3
—
—
—
0
0
19
111
1.60
1.09
1.6
1.7
—
—
—
0
0
5
20
2.32
1.05
1.8
1.1
—
—
—
0
0
18
105
1.60
1.04
2.9
2.0
—
—
—
0
0
246
2064
1.14
1.01
6.4
4.7
29.31
31.63
u/l
0.89
235
1986
35
435
0.74
1.00
1.3
1.9
—
—
—
0
0
10
50
1.86
0.96
1.6
1.2
—
—
—
0
0
44
525
0.77
0.96
1.5
1.4
—
—
—
0
0
88
683
1.21
0.94
1.1
1.2
1.89
1.11
u/ml
0.25
59
473
6
25
2.23
0.93
1.3
1.2
4.02
1.55
nmol/l
—
6
25
23
147
1.46
0.92
1.7
1.5
—
—
—
0
0
16
94
1.59
0.91
3.9
5.8
0.56
0.73
index
0.26
16
94
63
473
1.25
0.91
1.1
1.1
8.61
7.63
u/ml
0.12
46
315
524
4628
1.12
0.89
3.0
2.5
5.20
5.36
mmol/l
4.86
501
4310
6
27
2.07
0.89
5.0
1.7
—
—
—
0
0
6
27
2.07
0.89
5.0
1.7
—
—
—
0
0
6
27
2.07
0.89
5.0
1.7
—
—
—
0
0
6
27
2.07
0.89
5.0
1.7
—
—
—
0
0
8
40
1.86
0.87
1.9
1.7
—
—
—
0
0
123
997
1.17
0.82
1.1
1.1
—
—
—
0
0
36
256
1.32
0.80
4.1
4.4
9.42
14.99
e6/l
0.35
26
177
36
256
1.32
0.80
4.2
4.4
635.00
16659.32
e6/l
0.50
26
185
14
83
1.57
0.79
1.9
1.7
—
—
—
0
0
9
51
1.64
0.73
1.0
1.4
—
—
—
0
0
9
51
1.64
0.73
1.0
1.4
—
—
—
0
0
9
51
1.64
0.73
1.0
1.4
—
—
—
0
0
34
244
1.30
0.73
1.1
1.2
2.89
6.55
iu/ml
—
8
40
9
52
1.61
0.72
1.0
1.5
—
—
—
0
0
7
37
1.76
0.71
1.6
1.6
—
—
—
0
0
9
54
1.55
0.69
1.0
1.4
—
—
—
0
0
9
54
1.55
0.69
1.0
1.5
—
—
—
0
0
93
750
1.17
0.69
1.2
1.3
3.35
3.09
u/ml
0.07
65
527
110
900
1.15
0.67
1.3
1.3
27.41
14.41
iu/ml
0.56
18
181
14
87
1.50
0.66
2.2
1.9
19.22
29.92
mg/l
—
9
48
216
1850
1.11
0.64
3.9
2.6
0.00
0.01
estimate
0.88
70
556
84
677
1.16
0.63
1.1
1.2
3.07
3.16
u/ml
0.03
64
487
451
4358
0.92
0.63
3.9
2.7
1.13
1.09
mmol/l
0.79
440
4188
5
27
1.72
0.63
2.4
4.6
25.00
85.26
u/l
—
5
27
5
27
1.72
0.63
1.4
1.9
—
—
—
0
0
101
827
1.15
0.62
1.3
1.2
5.29
5.17
u/ml
0.01
34
278
494
4751
0.92
0.61
4.1
2.9
1.44
1.42
mmol/l
0.42
481
4569
205
1758
1.10
0.59
4.8
2.9
—
—
—
0
0
10
59
1.58
0.59
1.1
1.5
—
—
—
0
0
13
82
1.48
0.59
2.2
1.7
6193.63
22463.02
e6/l
—
8
59
8
49
1.52
0.58
1.5
1.2
—
—
—
0
0
6
34
1.64
0.56
1.3
1.4
149.97
209.12
pmol/l
—
6
34
6
35
1.59
0.54
1.3
1.1
—
—
—
0
0
9
56
1.49
0.54
1.3
1.7
—
—
—
0
0
12
76
1.47
0.54
1.1
1.2
—
—
—
0
0
98
812
1.13
0.53
1.4
1.5
—
—
—
0
0
6
90
0.62
0.52
6.5
1.5
12.95
12.83
%
—
6
90
65
524
1.16
0.51
2.0
1.8
—
—
—
0
0
7
42
1.55
0.49
1.3
1.0
1.09
1.05
ratio
—
7
36
28
319
0.81
0.48
1.5
1.3
—
—
—
0
0
25
184
1.27
0.48
1.9
1.5
37.76
39.82
nmol/l
0.20
25
178
12
78
1.43
0.48
1.6
1.9
143.00
122.18
%
0.42
12
78
12
78
1.43
0.48
1.4
1.2
—
—
—
0
0
7
43
1.51
0.48
1.4
1.1
—
—
—
0
0
7
45
1.44
0.46
1.4
1.1
—
—
—
0
0
502
4792
0.93
0.46
4.1
3.0
2.68
2.67
mmol/l
0.19
490
4603
7
46
1.41
0.45
1.4
1.1
—
—
—
0
0
7
46
1.41
0.45
1.4
1.1
—
—
—
0
0
7
46
1.41
0.45
1.4
1.1
—
—
—
0
0
15
104
1.34
0.44
1.3
1.2
—
—
—
0
0
506
4824
0.94
0.44
4.2
3.0
4.46
4.42
mmol/l
0.45
495
4661
142
1219
1.09
0.42
1.5
1.6
—
—
—
0
0
5
30
1.55
0.42
1.0
1.2
—
—
—
0
0
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
27
206
1.22
0.40
16.6
8.3
49.53
57.62
%
0.92
27
199
5
33
1.41
0.38
1.2
1.1
—
—
—
0
0
11
74
1.38
0.38
1.0
1.0
—
—
—
0
0
21
157
1.24
0.38
3.7
2.1
—
—
—
0
0
65
539
1.13
0.37
1.6
1.6
66.43
59.81
ug/l
0.45
65
539
5
34
1.36
0.37
1.2
1.1
—
—
—
0
0
28
217
1.20
0.37
1.4
1.2
13.40
226.32
iu/ml
—
5
71
330
2943
1.06
0.36
4.8
3.3
—
—
estimate
—
0
0
6
40
1.39
0.35
1.0
1.4
—
—
—
0
0
6
41
1.36
0.34
4.2
6.0
216.83
198.21
ug/l
—
6
41
18
134
1.25
0.34
3.6
2.3
—
—
—
0
0
21
233
0.83
0.31
1.4
1.1
—
—
—
0
0
7
48
1.35
0.31
1.3
1.1
—
—
—
0
0
70
592
1.10
0.30
1.8
1.8
—
—
—
0
0
7
50
1.30
0.30
1.1
1.2
—
—
nmol/l
—
0
0
15
111
1.26
0.30
3.3
3.7
1.60
4.92
ug/l
—
8
64
11
78
1.31
0.29
1.2
1.2
0.56
0.58
ratio
—
5
45
8
58
1.28
0.28
1.1
1.3
—
—
—
0
0
21
227
0.85
0.25
1.4
1.1
—
—
—
0
0
14
157
0.82
0.24
1.6
1.6
—
—
—
0
0
18
141
1.19
0.23
3.7
2.1
—
—
—
0
0
36
300
1.12
0.22
1.6
1.5
0.00
0.01
iu/ml
—
8
55
5
38
1.22
0.22
1.2
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
5
39
1.19
0.21
1.2
1.1
—
—
—
0
0
8
98
0.75
0.21
1.4
1.2
0.04
1.14
u/ml
—
8
98
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
18
193
0.86
0.20
1.8
1.6
—
—
—
0
0
6
48
1.16
0.19
1.2
1.1
—
—
—
0
0
12
92
1.21
0.19
1.5
2.3
10.30
9.37
mg/l
0.39
12
87
47
403
1.08
0.18
1.7
1.4
—
—
—
0
0
11
84
1.22
0.18
1.5
1.3
0.54
0.45
ug/l
—
5
17
18
146
1.15
0.16
1.2
1.1
—
—
—
0
0
27
275
0.91
0.15
1.1
1.0
1.52
1.50
g/l
0.14
27
275
58
506
1.07
0.15
2.2
2.2
7.30
15.37
au/ml
—
6
58
7
82
0.79
0.14
1.0
1.2
0.39
4.19
u/ml
—
7
71
10
109
0.85
0.13
1.1
1.1
—
—
—
0
0
72
699
0.95
0.13
1.7
1.6
73.42
58.70
ug/l
1.40
60
622
118
1056
1.04
0.13
2.3
2.3
18.92
60.14
ng/l
0.99
37
366
487
4460
1.03
0.13
11.9
6.6
112.49
108.87
ml/min/173m2
3.16
386
3461
15
123
1.13
0.12
1.1
1.1
1.41
1.38
g/l
0.24
15
116
69
612
1.05
0.11
1.6
1.7
—
—
—
0
0
15
124
1.12
0.11
3.9
9.6
23.93
23.19
mmol/l
0.23
15
117
12
126
0.88
0.11
1.2
1.3
6.92
8.10
u/ml
0.07
12
117
27
269
0.93
0.10
1.1
1.7
2.13
3.75
mg/l
1.60
21
181
58
516
1.04
0.09
1.3
1.3
—
—
—
0
0
6
50
1.11
0.09
2.0
2.8
15.05
17.73
umol/l
—
6
50
12
99
1.12
0.08
1.2
1.1
—
—
—
0
0
12
124
0.90
0.08
1.3
1.3
0.30
13.71
u/ml
4.20
12
116
6
54
1.03
0.08
1.5
1.5
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
59
0.78
0.08
1.0
1.2
—
57.64
—
0
11
439
4032
1.02
0.08
6.5
4.1
24.97
26.47
u/l
0.54
422
3905
6
66
0.84
0.07
1.0
1.1
—
—
—
0
0
27
265
0.94
0.07
1.4
1.6
6.45
15.40
u/ml
0.57
15
179
13
132
0.91
0.07
1.1
1.6
—
1664.00
—
0
5
772
7130
1.02
0.06
4.2
4.1
—
—
—
0
0
67
638
0.97
0.06
1.7
1.5
1.14
1.20
ratio
0.19
34
400
67
638
0.97
0.06
1.7
1.5
0.95
0.93
ratio
0.12
34
399
67
636
0.97
0.05
1.7
1.5
0.97
1.12
ratio
0.69
34
397
11
93
1.10
0.04
1.9
1.2
—
—
—
0
0
24
233
0.95
0.04
1.7
1.7
3.77
5.49
u/ml
—
6
57
14
139
0.93
0.04
2.4
2.5
1.13
2.14
mmol/l
—
9
113
769
7141
0.98
0.04
20.7
11.2
20.68
22.34
mg/l
0.82
599
5301
76
691
1.02
0.04
5.1
5.0
212.69
10.65
mg/mmol
0.51
56
545
101
949
0.98
0.03
1.8
1.6
1.42
1.35
%
0.43
92
860
10
85
1.09
0.03
10.1
4.2
1.44
1.71
mmol/l
—
10
85
20
177
1.05
0.03
2.3
2.2
56.25
34.13
u/ml
0.41
20
171
12
104
1.07
0.02
1.2
1.1
—
—
—
0
0
26
233
1.03
0.02
1.5
1.7
—
—
—
0
0
34
307
1.03
0.02
5.0
3.2
—
—
—
0
0
23
206
1.04
0.02
2.2
2.5
—
—
—
0
0
56
527
0.98
0.02
1.3
1.3
237.38
242.86
miu/ml
0.04
29
270
29
276
0.97
0.01
1.1
1.0
0.95
0.85
g/l
0.56
29
276
139
1295
0.99
0.01
1.7
1.7
1282.27
961.68
mu/l
2.30
123
1164
23
219
0.97
0.01
1.1
1.3
0.76
2.67
u/ml
0.92
12
145
26
235
1.03
0.01
2.2
2.3
1.65
3.38
iu/l
2.94
12
107
27
256
0.98
0.00
1.0
1.0
-1.06
-2.16
mmol/l
—
5
53
41
379
1.00
0.00
1.6
1.7
0.19
0.20
mg/l
0.04
12
156
10
95
0.97
0.00
1.1
1.1
25.94
32.62
iu/ml
—
10
95
104
968
0.99
0.00
2.8
2.5
13501.00
8150.17
u/l
0.38
38
371
11
99
1.03
0.00
1.0
1.1
0.18
2.40
u/ml
1.52
11
99
67
623
1.00
0.00
1.7
1.5
—
—
—
0
0
36
332
1.00
0.00
1.0
1.0
11.25
8.43
mu/l
0.68
30
286
0
7
0.00
-0.00
0.0
2.9
—
4.71
—
0
7
9
87
0.96
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.9
—
11.66
—
0
7
5
51
0.91
-0.00
1.0
1.4
79.00
64.47
ug/l
—
5
51
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
8460.00
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
0.94
-0.00
8.8
3.5
5.32
4.94
kpa
—
6
59
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_SHORT – Short stature, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).